Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study

Wallis, Christopher J D, Lo, Kirk, Lee, Yuna, Krakowsky, Yonah, Garbens, Alaina, Satkunasivam, Raj, Herschorn, Sender, Kodama, Ronald T, Cheung, Patrick, Narod, Steven A, Nam, Robert K · 2016 · The Lancet Diabetes & Endocrinology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(16)00112-1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 27

  1. Traish, 2014, Adverse health effects of testosterone deficiency (TD) in men, Steroids, 88, 106, 10.1016/j.steroids.2014.05.010 · DOI
  2. Bhasin, 2006, Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metabol, 91, 1995, 10.1210/jc.2005-2847 · DOI · Paper page
  3. Ohlsson, 2011, High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden, J Am Coll Cardiol, 58, 1674, 10.1016/j.jacc.2011.07.019 · DOI · Paper page
  4. Xu, 2013, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials, BMC Med, 11, 108, 10.1186/1741-7015-11-108 · DOI · Paper page
  5. Baillargeon, 2014, Risk of myocardial infarction in older men receiving testosterone therapy, Ann Pharmacother, 48, 1138, 10.1177/1060028014539918 · DOI · Paper page
  6. Sharma, 2015, Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men, Eur Heart J, 36, 2706, 10.1093/eurheartj/ehv346 · DOI · Paper page
  7. Shores, 2012, Testosterone treatment and mortality in men with low testosterone levels, J Clin Endocrinol Metabol, 97, 2050, 10.1210/jc.2011-2591 · DOI · Paper page
  8. Muraleedharan, 2013, Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes, Eur J Endocrinol, 169, 725, 10.1530/EJE-13-0321 · DOI · Paper page
  9. Anderson, 2015, Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system, Am J Cardiol, 117, 794, 10.1016/j.amjcard.2015.11.063 · DOI
  10. Corona, 2015, Testosterone replacement therapy and cardiovascular risk: a review, World J Mens Health, 33, 130, 10.5534/wjmh.2015.33.3.130 · DOI
  11. Goodman, 2015, American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk, Endocr Pract, 21, 1066, 10.4158/EP14434.PS · DOI
  12. Dean, 2005, Long-term effects of testim(r) 1% testosterone gel in hypogonadal men, Rev Urol, 7, 87
  13. 2015, Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies, Lancet, 385, 1835, 10.1016/S0140-6736(14)61687-1 · DOI · Paper page
  14. Etminan, 2015, Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study, Pharmacotherapy, 35, 72, 10.1002/phar.1534 · DOI
  15. Levy, 2003, Coding accuracy of administrative drug claims in the Ontario Drug Benefit database, Can J Clin Pharmacol, 10, 67
  16. Tu, 1999, Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992–1996, CMAJ, 161, 1257
  17. Hux, 2002, Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm, Diabetes Care, 25, 512, 10.2337/diacare.25.3.512 · DOI · Paper page
  18. Robles, 1988, An application of capture-recapture methods to the estimation of completeness of cancer registration, J Clin Epidemiol, 41, 495, 10.1016/0895-4356(88)90052-2 · DOI · Paper page
  19. Mittmann, 2012, Population-based home care services in breast cancer: utilization and costs, Curr Oncol, 19, e383, 10.3747/co.19.1078 · doi:10.3747/co.19.1078
  20. Piszczek, 2014, The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men, PLoS One, 9, e98003, 10.1371/journal.pone.0098003 · DOI
  21. Austin, 2009, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research, Commun Stat Simul Comput, 38, 1228, 10.1080/03610910902859574 · DOI · Paper page
  22. Shintani, 2009, Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies, Crit Care Med, 37, 2939, 10.1097/CCM.0b013e3181b7fbbb · DOI · Paper page
  23. Daniel, 2015, Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure, Am J Obstet Gynecol, 212, 307.e1, 10.1016/j.ajog.2014.09.028 · DOI
  24. Stricker, 2010, Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies, Eur J Epidemiol, 25, 245, 10.1007/s10654-010-9451-7 · DOI
  25. Morgentaler, 2014, Deaths and cardiovascular events in men receiving testosterone, JAMA, 311, 961, 10.1001/jama.2014.392 · DOI
  26. Cui, 2014, The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis, Prostate Cancer Prostatic Dis, 17, 132, 10.1038/pcan.2013.60 · DOI
  27. Hernan, 2008, Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease, Epidemiology, 19, 766, 10.1097/EDE.0b013e3181875e61 · DOI · Paper page

Cited by

See all 161

Metadata

Authors
Wallis, C. J. D., Lo, K., Lee, Y., Krakowsky, Y., Garbens, A., Satkunasivam, R., Herschorn, S., Kodama, R. T., Cheung, P., Narod, S. A., & Nam, R. K.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2016-06
Volume
4
Issue
6
Pages
498-506
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2346770749
Cited by
161
References
3
FWCI
20.49
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Government of Ontario
  • Physicians' Services Incorporated Foundation
  • Canadian Institutes of Health Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. https://app.cochat.ai/papers/10.1016/s2213-8587(16)00112-1
The paper
Wallis, C. J. D., Lo, K., Lee, Y., Krakowsky, Y., Garbens, A., Satkunasivam, R., Herschorn, S., Kodama, R. T., Cheung, P., Narod, S. A., & Nam, R. K. (2016). Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(16)00112-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.